Found: 13
Select item for more details and to access through your institution.
A disease progression model estimating the benefit of tolvaptan on time to end-stage renal disease for patients with rapidly progressing autosomal dominant polycystic kidney disease.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Cost-effectiveness analysis of universal noninvasive testing for post-treatment confirmation of Helicobacter pylori eradication and the impact of patient adherence.
- Published in:
- Patient Preference & Adherence, 2016, v. 10, p. 1025, doi. 10.2147/PPA.S102760
- By:
- Publication type:
- Article
Impact of patient adherence on the cost-effectiveness of noninvasive tests for the initial diagnosis of Helicobacter pylori infection in the United States.
- Published in:
- Patient Preference & Adherence, 2016, v. 10, p. 45, doi. 10.2147/PPA.S93320
- By:
- Publication type:
- Article
The Humanistic and Economic Burden of Chronic Idiopathic Constipation in the USA: A Systematic Literature Review.
- Published in:
- Clinical & Experimental Gastroenterology, 2020, v. 13, p. 255, doi. 10.2147/CEG.S239205
- By:
- Publication type:
- Article
A post hoc analysis of Projected Retained Ability Scores (PRAS) for the longitudinal assessment of cognitive functioning in patients with neuronopathic mucopolysaccharidosis II receiving intrathecal idursulfase-IT.
- Published in:
- Orphanet Journal of Rare Diseases, 2023, v. 18, n. 1, p. 1, doi. 10.1186/s13023-023-02957-2
- By:
- Publication type:
- Article
Mortality risk in patients with autosomal dominant polycystic kidney disease.
- Published in:
- BMC Nephrology, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s12882-024-03484-3
- By:
- Publication type:
- Article
Cost-Effectiveness of Lovotibeglogene Autotemcel (Lovo-Cel) Gene Therapy for Patients with Sickle Cell Disease and Recurrent Vaso-Occlusive Events in the United States.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 6, p. 693, doi. 10.1007/s40273-024-01385-9
- By:
- Publication type:
- Article
A Matching-Adjusted Indirect Comparison of Sonidegib and Vismodegib in Advanced Basal Cell Carcinoma.
- Published in:
- Journal of Skin Cancer, 2017, p. 1, doi. 10.1155/2017/6121760
- By:
- Publication type:
- Article
Correction to: Expected Budget Impact and Health Outcomes of Expanded Use of Vagus Nerve Stimulation Therapy for Drug-Resistant Epilepsy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Expected Budget Impact and Health Outcomes of Expanded Use of Vagus Nerve Stimulation Therapy for Drug-Resistant Epilepsy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Cost- Effectiveness of Avatrombopag for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease.
- Published in:
- ClinicoEconomics & Outcomes Research, 2020, v. 12, p. 515, doi. 10.2147/CEOR.S262772
- By:
- Publication type:
- Article
US Budget Impact Model for Selinexor in Relapsed or Refractory Multiple Myeloma.
- Published in:
- ClinicoEconomics & Outcomes Research, 2020, v. 12, p. 317, doi. 10.2147/CEOR.S251070
- By:
- Publication type:
- Article
A framework for assessing the lifetime economic burden of congenital cytomegalovirus in the United States.
- Published in:
- Cost Effectiveness & Resource Allocation, 2019, v. 17, n. 1, p. N.PAG, doi. 10.1186/s12962-019-0189-0
- By:
- Publication type:
- Article